Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Scandium International Mining Announces Voting Results from Annual General Meeting of Shareholders
-
Navios Maritime Holdings Inc.’s Tender Offer Deadline is Midnight on June 7, 2024 to Receive $4.75 in Cash for All Holders of ADSs (Series G & H)
-
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers
-
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibitor VYN201
-
Sanas Unveils Free-Forever Noise Cancellation for Contact Center Agents Globally
-
Par Pacific Announces New Intermediation Financing Agreement and Confirms Increase in ABL Commitments to up to $1.4 billion
-
CryptoHeap's New Strategy Aims to Optimize Crypto Staking During Market Fluctuations
-
Asia Broadband Digital Asset Division to Launch Its 3rd Limited Edition NFT Collection on the Bitcoin Network
-
Improving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolio
-
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
-
Lelantos Holdings Announces $1 Million-Plus in Residential Solar Sales for Eco Management Systems Over the Past 3 Months
-
Rocky Mountain Chocolate Factory Announces Separation of CEO and Chair Roles
-
Satelytics Announces Breakthrough in Shoreline Management for Georgia Power Using AI-Powered Geospatial Analytics
-
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation
-
XWELL Introduces New Esthetic Facial Services to Naples Wax Center Locations
-
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024
-
ConnectWise Authorized as CVE Numbering Authority by the CVE Program
-
Clene to Present at the Emerging Growth Conference
-
New AI agent for venture capital: 100x cheaper, 5x faster and on-par quality with humans
-
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
-
Super League CEO Ann Hand to Participate in H.C. Wainwright Virtual Fireside Chat
-
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
-
ARMLOGI BECOMES AN OFFICIAL AUTHORIZED WAREHOUSER FOR TEMU SELLERS
-
Drucker Alumni Pledge $1 Million to Fellowship Fund, Supporting the Next Generation of Business Leaders
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
-
NFI Buys Brokerage Business Unit of Transfix
-
VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
-
Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
-
Talkspace Appoints John Mooney as Chief Product Officer
-
CryptoHeap's New Strategy Aims to Optimize Crypto Staking During Market Fluctuations
-
A UNIQUE EXPLORATION OF GAME WRITING ROLLS INTO THE AMERICAN WRITERS MUSEUM
-
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
-
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
-
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
-
Astiva Health Summer Gala: An Inaugural Celebration
-
Billor Fulfills the American Dream by Turning Truck Drivers into Entrepreneurs with Fintech and AI
-
Safe Harbor Financial Announces New Small Business Line of Credit Program with the Origination of Three New Lines of Credit
-
Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at EASL 2024 Congress
-
73% of Millennials Plan to Indulge in Self-Gifting This Holiday Season
-
Byrna Technologies Announces Record Preliminary Q2 2024 Results: Revenues Exceed $20 Million; Q2 Production Totals Over 48,000 Units
-
Equip’s Second Annual Report Highlights First-Rate Patient Outcomes, Company Growth
-
Iterum Therapeutics to Present Data at ASM Microbe 2024
-
Survey: B2B Web Store Woes Drive Manufacturing Buyers Elsewhere
-
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
-
Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions
-
OKX Ventures Announces Strategic Investment in GoPlus to Enhance Blockchain Security
-
SDVerse Leverages Spryker to Drive the Future of Software-Defined Vehicles
-
Acorn Secures $5M Contract with Leading Wireless Provider for Remote Monitoring and Control of Cell Tower Backup Generators
